APM
Price
$1.63
Change
+$0.08 (+5.16%)
Updated
Oct 20, 04:58 PM (EDT)
Capitalization
12.62M
Intraday Buy/Sell Signals
NEVPF
Price
$0.03
Change
-$0.00 (-0.00%)
Updated
Jan 23 closing price
Capitalization
45.13M
Intraday Buy/Sell Signals
Interact to see
Advertisement

APM vs NEVPF

Header iconAPM vs NEVPF Comparison
Open Charts APM vs NEVPFBanner chart's image
Aptorum Group
Price$1.63
Change+$0.08 (+5.16%)
Volume$100
Capitalization12.62M
Abliva AB
Price$0.03
Change-$0.00 (-0.00%)
Volume$58.9K
Capitalization45.13M
APM vs NEVPF Comparison Chart in %
APM
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
APM vs. NEVPF commentary
Oct 21, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is APM is a Hold and NEVPF is a Hold.

Interact to see
Advertisement
COMPARISON
Comparison
Oct 21, 2025
Stock price -- (APM: $1.55 vs. NEVPF: $0.03)
Brand notoriety: APM and NEVPF are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: APM: 1% vs. NEVPF: 100%
Market capitalization -- APM: $12.62M vs. NEVPF: $45.13M
APM [@Biotechnology] is valued at $12.62M. NEVPF’s [@Biotechnology] market capitalization is $45.13M. The market cap for tickers in the [@Biotechnology] industry ranges from $106.87B to $0. The average market capitalization across the [@Biotechnology] industry is $2.05B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

APM’s FA Score shows that 2 FA rating(s) are green whileNEVPF’s FA Score has 0 green FA rating(s).

  • APM’s FA Score: 2 green, 3 red.
  • NEVPF’s FA Score: 0 green, 5 red.
According to our system of comparison, APM is a better buy in the long-term than NEVPF.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

APM’s TA Score shows that 3 TA indicator(s) are bullish.

  • APM’s TA Score: 3 bullish, 6 bearish.

Price Growth

APM (@Biotechnology) experienced а -6.63% price change this week, while NEVPF (@Biotechnology) price change was 0.00% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was +4.76%. For the same industry, the average monthly price growth was +18.12%, and the average quarterly price growth was +72.90%.

Industries' Descriptions

@Biotechnology (+4.76% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
NEVPF($45.1M) has a higher market cap than APM($12.6M). NEVPF YTD gains are higher at: -22.222 vs. APM (-44.643). APM has higher annual earnings (EBITDA): -9.6M vs. NEVPF (-87.99M). NEVPF has more cash in the bank: 32.7M vs. APM (2.01M). APM has higher revenues than NEVPF: APM (431K) vs NEVPF (0).
APMNEVPFAPM / NEVPF
Capitalization12.6M45.1M28%
EBITDA-9.6M-87.99M11%
Gain YTD-44.643-22.222201%
P/E Ratio3.00N/A-
Revenue431K0-
Total Cash2.01M32.7M6%
Total Debt3.28MN/A-
FUNDAMENTALS RATINGS
APM vs NEVPF: Fundamental Ratings
APM
NEVPF
OUTLOOK RATING
1..100
5050
VALUATION
overvalued / fair valued / undervalued
1..100
33
Fair valued
86
Overvalued
PROFIT vs RISK RATING
1..100
100100
SMR RATING
1..100
9599
PRICE GROWTH RATING
1..100
4942
P/E GROWTH RATING
1..100
23100
SEASONALITY SCORE
1..100
377

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

APM's Valuation (33) in the Pharmaceuticals Major industry is somewhat better than the same rating for NEVPF (86) in the null industry. This means that APM’s stock grew somewhat faster than NEVPF’s over the last 12 months.

APM's Profit vs Risk Rating (100) in the Pharmaceuticals Major industry is in the same range as NEVPF (100) in the null industry. This means that APM’s stock grew similarly to NEVPF’s over the last 12 months.

APM's SMR Rating (95) in the Pharmaceuticals Major industry is in the same range as NEVPF (99) in the null industry. This means that APM’s stock grew similarly to NEVPF’s over the last 12 months.

NEVPF's Price Growth Rating (42) in the null industry is in the same range as APM (49) in the Pharmaceuticals Major industry. This means that NEVPF’s stock grew similarly to APM’s over the last 12 months.

APM's P/E Growth Rating (23) in the Pharmaceuticals Major industry is significantly better than the same rating for NEVPF (100) in the null industry. This means that APM’s stock grew significantly faster than NEVPF’s over the last 12 months.

TECHNICAL ANALYSIS
Technical Analysis
APMNEVPF
RSI
ODDS (%)
N/A
N/A
Stochastic
ODDS (%)
Bullish Trend 4 days ago
83%
N/A
Momentum
ODDS (%)
Bearish Trend 4 days ago
84%
N/A
MACD
ODDS (%)
Bearish Trend 4 days ago
90%
N/A
TrendWeek
ODDS (%)
Bearish Trend 4 days ago
90%
Bullish Trend 4 days ago
14%
TrendMonth
ODDS (%)
Bearish Trend 4 days ago
90%
Bullish Trend 4 days ago
14%
Advances
ODDS (%)
Bullish Trend 15 days ago
81%
N/A
Declines
ODDS (%)
Bearish Trend 5 days ago
90%
N/A
BollingerBands
ODDS (%)
Bearish Trend 4 days ago
89%
N/A
Aroon
ODDS (%)
Bullish Trend 4 days ago
83%
N/A
View a ticker or compare two or three
Interact to see
Advertisement
APM
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
TSLA439.3110.56
+2.46%
Tesla
AAPL252.294.84
+1.96%
Apple
BTC.X108666.7100001468.453100
+1.37%
Bitcoin cryptocurrency
SPY664.393.75
+0.57%
SPDR® S&P 500® ETF
GME23.070.12
+0.52%
GameStop Corp

APM and

Correlation & Price change

A.I.dvisor indicates that over the last year, APM has been loosely correlated with PHGE. These tickers have moved in lockstep 60% of the time. This A.I.-generated data suggests there is some statistical probability that if APM jumps, then PHGE could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To APM
1D Price
Change %
APM100%
+1.97%
PHGE - APM
60%
Loosely correlated
-0.29%
NEVPF - APM
40%
Loosely correlated
N/A
MDXG - APM
29%
Poorly correlated
+0.90%
ONCO - APM
28%
Poorly correlated
-2.59%
BMNDF - APM
27%
Poorly correlated
N/A
More

NEVPF and

Correlation & Price change

A.I.dvisor indicates that over the last year, NEVPF has been closely correlated with MLTX. These tickers have moved in lockstep 70% of the time. This A.I.-generated data suggests there is a high statistical probability that if NEVPF jumps, then MLTX could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To NEVPF
1D Price
Change %
NEVPF100%
N/A
MLTX - NEVPF
70%
Closely correlated
-2.77%
IMA - NEVPF
66%
Loosely correlated
-0.66%
ATYR - NEVPF
65%
Loosely correlated
+2.00%
REPL - NEVPF
64%
Loosely correlated
-3.64%
SPRB - NEVPF
61%
Loosely correlated
+0.77%
More